Mupirocin

莫匹罗星

Report date: 2026/04/24 20:01:59

Base Information

Drug NameMupirocin
Drug Alias Name莫比罗星MupirocinaCentanyPseudomonic acidMupirocinum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA Ligase (ATP) inhibitors
TargetsRNA Ligase (ATP)
Therapy Area/IndicationsMucositisImpetigoStaphylococcal Infections +[4] 
Global Approved IndicationsImpetigoGram-Positive Bacterial Infections
Approved Indications in ChinaGram-Positive Bacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1985/01/01
Country/TerritoryCanadaUnited StatesSpain +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Yuxi Pharmaceutical Technology Co LtdGlaxosmithkline PlcLaboratorio Reig Jofre Sa +[5] 
Inactive CompaniesReig Jofre GroupPerrigo New York, IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsMucositisImpetigoStaphylococcal Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeD06AX09R01AX06
Related LinksWikipediaDrugBankKEGG